Akash Maniam/LinkedIn
Apr 16, 2025, 16:20
Akash Maniam: The ADC Revolution Continues – Appreciating Structural and Toxicity Differences
Akash Maniam, Medical Oncologist at Portsmouth Hospitals University NHS Trust, shared on LinkedIn about a recent paper by Yongmei Yin et al. published in Nature:
“The ADC revolution continues. Interesting seeing the toxicity differences between this and sacituzumab-govitecan. Emphasises how important the structures of ADCs are and why we should take the time to appreciate the differences between them.
That’s how we can make optimal clinical decisions on dosing, schedules and toxicity counselling.”
Authors: Yongmei Yin et al.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Aug 12, 2025, 12:21
Aug 12, 2025, 12:18
Aug 12, 2025, 12:18
Aug 12, 2025, 12:12
Aug 12, 2025, 11:59
Aug 12, 2025, 11:29
Aug 12, 2025, 11:19
Aug 12, 2025, 11:14
Aug 12, 2025, 11:04
Aug 12, 2025, 11:03